ABMT — Advanced Biomedical Technologies Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.03m
- $6.37m
- $0.12m
Annual cashflow statement for Advanced Biomedical Technologies, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2016 October 31st | 2017 October 31st | 2018 October 31st | 2019 October 31st | 2020 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.725 | -0.692 | -0.953 | -0.949 | -0.672 |
| Depreciation | |||||
| Non-Cash Items | 0.071 | 0.053 | 0.067 | 0.028 | 0.072 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.252 | 0.067 | 0.038 | 0.157 | 1.19 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Cash from Operating Activities | -0.372 | -0.558 | -0.832 | -0.743 | 0.647 |
| Capital Expenditures | -0.002 | -0 | -0.064 | -0.019 | -0.031 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.001 | 0.001 | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.003 | 0.001 | -0.064 | -0.019 | -0.031 |
| Financing Cash Flow Items | -0.05 | -0.048 | -0.035 | 0.009 | -0.034 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.344 | 0.558 | 0.896 | 0.76 | -0.428 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.032 | 0.001 | -0.001 | -0.001 | 0.196 |